Past and Current Status Later this year the Food and Drug Administration (FDA) will decide whether MDMA, the drug commonly known as "ecstasy," is a medicine.
Mental Health
Prescriptions of asthma drug montelukast remain high despite warnings from the FDA about psychiatric side effects, The New York Times reported Jan. 9.
CMS proposed new behavioral network adequacy standards for Medicare Advantage plans, but some groups are concerned there aren't enough providers to meet them.
Prescriptions for stimulant and non-stimulant ADHD treatments surged during the COVID-19 pandemic even as use of other psychiatric medications stayed relatively flat, a study published Jan. 10 in JAMA Psychiatry found.
Meta is implementing more features to direct teenagers to mental health resources and hide potentially sensitive content on Facebook and Instagram.
Individuals taking GLP-1 drugs Ozempic and Wegovy had a slightly lower incidence of suicidal ideation than those taking other forms of weight loss drugs, a study published Jan. 5 in Nature found.
Hawaii is the best state for access to psychotherapy, according to an analysis from Milliman.
Tricare, which provides health coverage for military personnel, dependents and retirees, may be falling short on some of its behavioral health goals, a report from the Government Accountability Office found.
NYC Health + Hospitals has partnered with the Institute for Human Identity to develop a training program focused on affirming therapy for LGBTQ+ patients.
Integrating physical and behavioral healthcare in Medicaid managed care did not result in significant changes in utilization, outcomes or social determinants of health, a study published Dec. 28 in JAMA Health Forum found.